Author

M. Paluschinski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

M. Castoldi· 2 shared T. Luedde· 2 shared C. Kordes· 1 shared H. C. Xu· 1 shared J. Bednarsch· 1 shared J. Schira-Heinen· 1 shared K. Stuehler· 1 shared L. R. Heij· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Castoldi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential modulation of miR-122 transcription by TGFbeta1/BMP6: implications for nonresolving inflammation and hepatocarcinogenesis

M. Paluschinski, C. Kordes, M. Vucur, V. Buettner, H. C. Xu, P. Shinde, P. A. Lang, T. Luedde, M. Castoldi

This study identifies miR-122 as a key regulator in inflammation-associated liver cancer, showing its differential modulation by TGFbeta1 and BMP6 and its link to chronic liver disease.

bioRxiv · Jun 30, 2023Cancer Biology

Uncovering novel roles of miR-122 in the pathophysiology of the liver: Potential interaction with NRF1 and E2F4 signaling

M. Paluschinski, J. Schira-Heinen, R. Pellegrino, L. R. Heij, J. Bednarsch, U. P. Neumann, T. Longerich, K. Stuehler, T. Luedde, M. Castoldi

This study identifies miR-122's role in liver disease by showing its antagonistic effects on NRF1 and E2F4 and its impact on proteins linked to malignancy.

bioRxiv · Jun 30, 2023Cancer Biology